BE ATC V08AB07 · updated 2 Nov 2026
Ioversol shortage in Belgium
Is there an Ioversol shortage in Belgium?
Yes. As of 2 Nov 2026, 3 Ioversol products are reported short in Belgium, the first since 12 Oct 2026. The company estimate for the return is 2 Nov 2026 (latest 11 Dec 2026). Main reason: manufacturing problem.
Also short in Canada, Italy, Spain, Czechia. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Optiray 350 mg I/ml (148,4 g/200 ml) inj. sol. i.arter. vial 200 ml | Guerbet | 12 Oct 2026 | 11 Dec 2026 | Manufacturing problem Delay in production |
| BE | Optiray 350 mg I/ml (371 g/500 ml) inj. sol. i.arter. vial 500 ml | Guerbet | 12 Oct 2026 | 2 Nov 2026 | Manufacturing problem Delay in production |
| BE | Optiray 350 mg I/ml (74,2 g/100 ml) inj. sol. i.arter. vial 100 ml | Guerbet | 12 Oct 2026 | 11 Dec 2026 | Manufacturing problem Delay in production |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.